Find Ursodeoxycholic Acid manufacturers, exporters & distributors on PharmaCompass

PharmaCompass

Synopsis

Synopsis

FDF DossiersDRUG PRODUCT COMPOSITIONS

239RELATED EXCIPIENT COMPANIES

399EXCIPIENTS BY APPLICATIONS

PATENTS & EXCLUSIVITIES

0

US Patents

0

US Exclusivities

0

Health Canada Patents

MARKET PLACE

DIGITAL CONTENT

0

Stock Recap #PipelineProspector

0

Weekly News Recap #Phispers

Chemistry

Click the arrow to open the dropdown
read-moreClick the button for full data set
Also known as: Ursodiol, 128-13-2, Actigall, Ursodeoxycholate, Udca, Ursofalk
Molecular Formula
C24H40O4
Molecular Weight
392.6  g/mol
InChI Key
RUDATBOHQWOJDD-UZVSRGJWSA-N
FDA UNII
724L30Y2QR

Ursodeoxycholic Acid
An epimer of chenodeoxycholic acid. It is a mammalian bile acid found first in the bear and is apparently either a precursor or a product of chenodeoxycholate. Its administration changes the composition of bile and may dissolve gallstones. It is used as a cholagogue and choleretic.
Ursodiol is a Bile Acid.
1 2D Structure

Ursodeoxycholic Acid

2 Identification
2.1 Computed Descriptors
2.1.1 IUPAC Name
(4R)-4-[(3R,5S,7S,8R,9S,10S,13R,14S,17R)-3,7-dihydroxy-10,13-dimethyl-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-17-yl]pentanoic acid
2.1.2 InChI
InChI=1S/C24H40O4/c1-14(4-7-21(27)28)17-5-6-18-22-19(9-11-24(17,18)3)23(2)10-8-16(25)12-15(23)13-20(22)26/h14-20,22,25-26H,4-13H2,1-3H3,(H,27,28)/t14-,15+,16-,17-,18+,19+,20+,22+,23+,24-/m1/s1
2.1.3 InChI Key
RUDATBOHQWOJDD-UZVSRGJWSA-N
2.1.4 Canonical SMILES
CC(CCC(=O)O)C1CCC2C1(CCC3C2C(CC4C3(CCC(C4)O)C)O)C
2.1.5 Isomeric SMILES
C[C@H](CCC(=O)O)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2[C@H](C[C@H]4[C@@]3(CC[C@H](C4)O)C)O)C
2.2 Other Identifiers
2.2.1 UNII
724L30Y2QR
2.3 Synonyms
2.3.1 MeSH Synonyms

1. 3 Alpha,7 Beta Dihydroxy 5 Beta Cholan 24 Oic Acid

2. 3 Alpha,7 Beta-dihydroxy-5 Beta-cholan-24-oic Acid

3. Acid, Deoxyursocholic

4. Acid, Ursacholic

5. Acid, Ursodeoxycholic

6. Cholit-ursan

7. Cholofalk

8. Delursan

9. Deoxyursocholic Acid

10. Destolit

11. Sodium Ursodeoxycholate

12. Urdox

13. Ursacholic Acid

14. Urso

15. Urso Heumann

16. Ursobilane

17. Ursochol

18. Ursodeoxycholate, Sodium

19. Ursodiol

20. Ursofalk

21. Ursogal

22. Ursolite

23. Ursolvan

2.3.2 Depositor-Supplied Synonyms

1. Ursodiol

2. 128-13-2

3. Actigall

4. Ursodeoxycholate

5. Udca

6. Ursofalk

7. Ursolvan

8. Urso

9. Delursan

10. Ursodesoxycholic Acid

11. Urso Forte

12. Destolit

13. Ursochol

14. Cholit-ursan

15. Litursol

16. Solutrat

17. Ursobilin

18. Ursodamor

19. Arsacol

20. Deursil

21. Lyeton

22. Ursacol

23. Urso Ds

24. Udcs

25. 3alpha,7beta-dihydroxy-5beta-cholan-24-oic Acid

26. Ursosan

27. Urso 250

28. 3-alpha,7-beta-dioxycholanic Acid

29. Ursocholic Acid, Deoxy-

30. 3-alpha,7-beta-dihydroxycholanic Acid

31. Ursonorm

32. Nsc 683769

33. (3alpha,5beta,7beta)-3,7-dihydroxycholan-24-oic Acid

34. 3-alpha,7-beta-dihydroxy-5-beta-cholanoic Acid

35. Ursodeoxycholicacid

36. (4r)-4-[(3r,5s,7s,8r,9s,10s,13r,14s,17r)-3,7-dihydroxy-10,13-dimethyl-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1h-cyclopenta[a]phenanthren-17-yl]pentanoic Acid

37. Nsc 657950

38. Brn 3219888

39. 3,7-dihydroxycholan-24-oic Acid

40. Peptarom

41. Ursodeoxycholic Acid [inn]

42. Chembl1551

43. Mls000028461

44. Chebi:9907

45. 724l30y2qr

46. Nsc-683769

47. Ursodiol [usan]

48. Antigall

49. Smr000058403

50. Urosiol

51. Cholan-24-oic Acid, 3,7-dihydroxy-, (3.alpha.,5.beta.,7.beta.)-

52. 7-beta-hydroxylithocholic Acid

53. Ursodexycholic Acid

54. Acido Ursodeossicolico [italian]

55. (r)-4-((3r,5s,7s,8r,9s,10s,13r,14s,17r)-3,7-dihydroxy-10,13-dimethylhexadecahydro-1h-cyclopenta[a]phenanthren-17-yl)pentanoic Acid

56. Acido Ursodeoxicolico

57. Acido Ursodeossicolico

58. Acido Ursodeoxicolico [inn-spanish]

59. Acidum Ursodeoxycholicum [inn-latin]

60. Acide Ursodesoxycholique

61. Acide Ursodesoxycholique [inn-french]

62. Acidum Ursodeoxycholicum

63. Actigall (tn)

64. Ursodiol (usp)

65. (4r)-4-[(1s,2s,5r,7s,9s,10r,11s,14r,15r)-5,9-dihydroxy-2,15-dimethyltetracyclo[8.7.0.0^{2,7}.0^{11,15}]heptadecan-14-yl]pentanoic Acid

66. Ccris 5502

67. Urso (tn)

68. Sr-01000737091

69. Ursodiol [usan:usp]

70. Einecs 204-879-3

71. Mfcd00003680

72. Ursodexycholate

73. Paptarom

74. Udiliv

75. Desol

76. Urdes

77. Unii-724l30y2qr

78. Urosdesoxycholate

79. 17-beta-(1-methyl-3-carboxypropyl)etiocholane-3-alpha,7-beta-diol

80. Ursodeoxycholoc Acid

81. Urosdesoxycholic Acid

82. 5beta-cholanic Acid-3alpha,7beta-diol

83. Ursodiol [inci]

84. Cholan-24-oic Acid, 3,7-dihydroxy-, (3alpha,5beta,7beta)-

85. 3alpha,7beta-dihydroxy-5beta-cholanic Acid

86. Ursodiol [mi]

87. Ursodiol (actigal Urso)

88. Ursodiol [vandf]

89. Prestwick0_000958

90. Prestwick1_000958

91. Prestwick2_000958

92. Prestwick3_000958

93. U0030

94. 7a-hydroxylithocholic Acid

95. Ursodiol [usp-rs]

96. Ec 204-879-3

97. U-9000

98. Schembl27200

99. Bspbio_000956

100. 4-10-00-01604 (beilstein Handbook Reference)

101. 7bet.-hydroxylithocholic Acid

102. Cid_31401

103. Mls001066373

104. Mls002548885

105. Spbio_003105

106. Ursodeoxycholic Acid, >=99%

107. Ursodiol [orange Book]

108. Bpbio1_001052

109. Gtpl7104

110. 7.beta.-hydroxylithocholic Acid

111. Ursodiol (ursodeoxycholic Acid)

112. 5-beta-cholan-24-oic Acid, 3-alpha,7-beta-dihydroxy-

113. Dtxsid6023731

114. Ursodiol [usp Monograph]

115. Bdbm53721

116. (3alpha,5beta,7beta,8xi)-3,7-dihydroxycholan-24-oic Acid

117. Hms1570p18

118. Hms2097p18

119. Hms2233l14

120. Hms3259a13

121. Hms3714p18

122. Ursodeoxycholic Acid (jp17/inn)

123. Ursodeoxycholic Acid [jan]

124. 3alpha,7beta-dihydroxycholanic Acid

125. Act02676

126. Cholan-24-oic Acid, 3,7-dihydroxy-, (3-alpha,5-beta,7-beta)-

127. Zinc3914809

128. 3a,7b-dihydroxy-5b-cholan-24-oate

129. Lmst04010033

130. S1643

131. Ursodeoxycholic Acid [mart.]

132. Ursodeoxycholic Acid [who-dd]

133. 5a-cholan-24-oic Acid-3a,7a-diol

134. Akos015955898

135. Ccg-220958

136. Cs-1932

137. Db01586

138. Ks-5243

139. Nc00487

140. Smp2_000012

141. 3.alpha.,7.beta.-dihydroxycholanic Acid

142. 3a,7a-dihydroxy-5a-holan-24-oic Acid

143. 3a,7b-dihydroxy-5b-cholan-24-oic Acid

144. Ncgc00179363-01

145. Ncgc00179363-12

146. Ac-18919

147. Cas#128-13-2

148. Cpd000058403

149. Hy-13771

150. Nci60_028904

151. Ursodeoxycholic Acid [ep Impurity]

152. Ursodeoxycholic Acid [ep Monograph]

153. Ab00513977

154. (3a,5b,7b)-3,7-dihydroxy-cholan-24-oate

155. 3alpha, 7beta-dihydroxy-5beta-cholanoic Acid

156. 5bet.-cholan-24-oic Acid-3alp.,7bet.-diol

157. (3a,5b,7b)-3,7-dihydroxycholan-24-oic Acid

158. C07880

159. D00734

160. ((3a,5b,7b)-3,7-dihydroxycholan-24-oic Acid

161. (3a,5b,7b)-3,7-dihydroxy-cholan-24-oic Acid

162. Ab00513977-09

163. Ab00513977_10

164. 3alp.,7bet.-dihydroxy-5bet.-cholan-24-oic Acid

165. A905413

166. Q241374

167. 3.alpha.,7.beta.-dihydroxy-5.beta.-cholanic Acid

168. J-005566

169. J-650210

170. Sr-01000737091-3

171. Sr-01000737091-4

172. Brd-k15697815-001-16-2

173. 3.alpha.,7.beta.-dihydroxy-5.beta.-cholan-24-oic Acid

174. Z2786051717

175. 3.alpha.,7.beta.-dihydroxy-5b-cholan-24-oic Acid

176. 5.beta.-cholan-24-oic Acid, 3.alpha.,7.beta.-dihydroxy-

177. Ursodiol, United States Pharmacopeia (usp) Reference Standard

178. Ursodeoxycholic Acid, British Pharmacopoeia (bp) Reference Standard

179. Ursodeoxycholic Acid, European Pharmacopoeia (ep) Reference Standard

180. 17.beta.-(1-methyl-3-carboxypropyl)etiocholane-3.alpha.,7.beta.-diol

181. 3,7-dihydroxycholan-24-oic Acid-, (3.alpha.,5.beta.,7.beta.)- #

182. Ursodeoxycholic Acid, 500 Mug/ml In Methanol, Certified Reference Material

183. Ursodiol, Pharmaceutical Secondary Standard; Certified Reference Material

184. Ursodeoxycholic Acid For System Suitability, European Pharmacopoeia (ep) Reference Standard

185. (4r)-4-[(1s,2s,5r,7s,9s,10r,11s,14r,15r)-5,9-dihydroxy-2,15-dimethyltetracyclo[8.7.0.02,1.011,1]heptadecan-14-yl]pentanoic Acid

186. (4r)-4-[(3r,5s,7s,8r,9s,10s,13r,14s,17r)-10,13-dimethyl-3,7-bis(oxidanyl)-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1h-cyclopenta[a]phenanthren-17-yl]pentanoic Acid

187. (4r)-4-[(3r,5s,7s,8r,9s,10s,13r,14s,17r)-3,7-dihydroxy-10,13-dimethyl-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1h-cyclopenta[a]phenanthren-17-yl]valeric Acid

188. 108609-27-4

2.4 Create Date
2005-03-26
3 Chemical and Physical Properties
Molecular Weight 392.6 g/mol
Molecular Formula C24H40O4
XLogP34.9
Hydrogen Bond Donor Count3
Hydrogen Bond Acceptor Count4
Rotatable Bond Count4
Exact Mass392.29265975 g/mol
Monoisotopic Mass392.29265975 g/mol
Topological Polar Surface Area77.8 Ų
Heavy Atom Count28
Formal Charge0
Complexity605
Isotope Atom Count0
Defined Atom Stereocenter Count10
Undefined Atom Stereocenter Count0
Defined Bond Stereocenter Count0
Undefined Bond Stereocenter Count0
Covalently Bonded Unit Count1
4 Drug and Medication Information
4.1 Drug Information
1 of 8  
Drug NameActigall
Drug LabelActigall is a bile acid available as 300 mg capsules suitable for oral administration.Actigall is ursodiol, USP (ursodeoxycholic acid), a naturally occurring bile acid found in small quantities in normal human bile and in the biles of certain other m...
Active IngredientUrsodiol
Dosage FormCapsule
RouteOral
Strength300mg
Market StatusPrescription
CompanyWatson Pharms

2 of 8  
Drug NameUrso 250
PubMed HealthUrsodiol (By mouth)
Drug ClassesGastrointestinal Agent
Drug LabelURSO 250 (ursodiol, 250 mg) is available as a film-coated tablet for oral administration. URSO Forte (ursodiol, 500 mg) is available as a scored film-coated tablet for oral administration. Ursodiol (ursodeoxycholic acid, UDCA) is a naturally occurrin...
Active IngredientUrsodiol
Dosage FormTablet
RouteOral
Strength250mg
Market StatusPrescription
CompanyForest Labs

3 of 8  
Drug NameUrso forte
PubMed HealthUrsodiol (By mouth)
Drug ClassesGastrointestinal Agent
Drug LabelURSO 250 (ursodiol, 250 mg) is available as a film-coated tablet for oral administration. URSO Forte (ursodiol, 500 mg) is available as a scored film-coated tablet for oral administration. Ursodiol (ursodeoxycholic acid, UDCA) is a naturally occurrin...
Active IngredientUrsodiol
Dosage FormTablet
RouteOral
Strength500mg
Market StatusPrescription
CompanyForest Labs

4 of 8  
Drug NameUrsodiol
PubMed HealthUrsodiol (By mouth)
Drug ClassesGastrointestinal Agent
Drug LabelUrsodiol Capsules, USP are a bile acid available as 300 mg capsules suitable for oral administration.Ursodiol, USP (ursodeoxycholic acid) is a naturally occurring bile acid found in small quantities in normal human bile and in the biles of certain ot...
Active IngredientUrsodiol
Dosage FormTablet; Capsule
RouteOral
Strength250mg; 500mg; 300mg
Market StatusPrescription
CompanyCorepharma; Epic Pharma; Par Pharm; Glenmark Generics; Teva Pharms; Lannett; Mylan; Impax Labs

5 of 8  
Drug NameActigall
Drug LabelActigall is a bile acid available as 300 mg capsules suitable for oral administration.Actigall is ursodiol, USP (ursodeoxycholic acid), a naturally occurring bile acid found in small quantities in normal human bile and in the biles of certain other m...
Active IngredientUrsodiol
Dosage FormCapsule
RouteOral
Strength300mg
Market StatusPrescription
CompanyWatson Pharms

6 of 8  
Drug NameUrso 250
PubMed HealthUrsodiol (By mouth)
Drug ClassesGastrointestinal Agent
Drug LabelURSO 250 (ursodiol, 250 mg) is available as a film-coated tablet for oral administration. URSO Forte (ursodiol, 500 mg) is available as a scored film-coated tablet for oral administration. Ursodiol (ursodeoxycholic acid, UDCA) is a naturally occurrin...
Active IngredientUrsodiol
Dosage FormTablet
RouteOral
Strength250mg
Market StatusPrescription
CompanyForest Labs

7 of 8  
Drug NameUrso forte
PubMed HealthUrsodiol (By mouth)
Drug ClassesGastrointestinal Agent
Drug LabelURSO 250 (ursodiol, 250 mg) is available as a film-coated tablet for oral administration. URSO Forte (ursodiol, 500 mg) is available as a scored film-coated tablet for oral administration. Ursodiol (ursodeoxycholic acid, UDCA) is a naturally occurrin...
Active IngredientUrsodiol
Dosage FormTablet
RouteOral
Strength500mg
Market StatusPrescription
CompanyForest Labs

8 of 8  
Drug NameUrsodiol
PubMed HealthUrsodiol (By mouth)
Drug ClassesGastrointestinal Agent
Drug LabelUrsodiol Capsules, USP are a bile acid available as 300 mg capsules suitable for oral administration.Ursodiol, USP (ursodeoxycholic acid) is a naturally occurring bile acid found in small quantities in normal human bile and in the biles of certain ot...
Active IngredientUrsodiol
Dosage FormTablet; Capsule
RouteOral
Strength250mg; 500mg; 300mg
Market StatusPrescription
CompanyCorepharma; Epic Pharma; Par Pharm; Glenmark Generics; Teva Pharms; Lannett; Mylan; Impax Labs

4.2 Drug Indication

The drug decreases the absorption of cholesterol and is used to dissolve (cholesterol) gallstones in patients as an alternative to a surgical procedure to remove the gallstones.


FDA Label


5 Pharmacology and Biochemistry
5.1 Pharmacology

Ursodiol (commonly known as ursodeoxycholic acid) is a product of metabolism of bacteria in the intestine. It is considered a secondary bile acid. The other type of bile acid, primary bile acids, are produced hepatically and subsequently stored in the gallbladder. When primary bile acids are secreted into the large intestine, they can be broken down into secondary bile acids by bacteria present in the intestine. Both types of bile acids assist in the metabolism of dietary fat. Ursodeoxycholic acid regulates cholesterol levels by slowing the rate at which the intestine is able to absorb cholesterol and also acts to break down micelles, which contain cholesterol. Because of this property, ursodeoxycholic acid is used to treat gall stones non-surgically.


5.2 MeSH Pharmacological Classification

Cholagogues and Choleretics

Gastrointestinal agents that stimulate the flow of bile into the duodenum (cholagogues) or stimulate the production of bile by the liver (choleretic). (See all compounds classified as Cholagogues and Choleretics.)


5.3 FDA Pharmacological Classification
5.3.1 Active Moiety
URSODIOL
5.3.2 FDA UNII
724L30Y2QR
5.3.3 Pharmacological Classes
Bile Acids and Salts [CS]; Bile Acid [EPC]
5.4 ATC Code

A05AA02

S76 | LUXPHARMA | Pharmaceuticals Marketed in Luxembourg | Pharmaceuticals marketed in Luxembourg, as published by d'Gesondheetskeess (CNS, la caisse nationale de sante, www.cns.lu), mapped by name to structures using CompTox by R. Singh et al. (in prep.). List downloaded from https://cns.public.lu/en/legislations/textes-coordonnes/liste-med-comm.html. Dataset DOI:10.5281/zenodo.4587355


A - Alimentary tract and metabolism

A05 - Bile and liver therapy

A05A - Bile therapy

A05AA - Bile acids and derivatives

A05AA02 - Ursodeoxycholic acid


5.5 Absorption, Distribution and Excretion

Route of Elimination

Only small quantities of ursodiol appear in the systemic circulation and very small amounts are excreted into urine. Eighty percent of lithocholic acid formed in the small bowel is excreted in the feces, but the 20% that is absorbed is sulfated at the 3-hydroxyl group in the liver to relatively insoluble lithocholyl conjugates which are excreted into bile and lost in feces.


5.6 Mechanism of Action

Ursodeoxycholic acid reduces elevated liver enzyme levels by facilitating bile flow through the liver and protecting liver cells. The main mechanism if anticholelithic. Although the exact process of ursodiol's anticholelithic action is not completely understood, it is thought that the drug is concentrated in bile and decreases biliary cholesterol by suppressing hepatic synthesis and secretion of cholesterol and by inhibiting its intestinal absorption. The reduced cholesterol saturation permits the gradual solubilization of cholesterol from gallstones, resulting in their eventual dissolution.


FDA Orange Book

read-more
read-more

01

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothSynergice, a Strides Pharma initiative, is a new gen B2B platform for diverse portofolio needs.

Flag India
Digital Content Digital Content

RLD : No

TE Code : AB

URSODIOL

Brand Name : URSODIOL

Dosage Form : CAPSULE;ORAL

Dosage Strength : 300MG

Approval Date : 2021-01-22

Application Number : 210344

RX/OTC/DISCN : RX

RLD : No

TE Code : AB

Strides Pharma Science

02

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothSynergice, a Strides Pharma initiative, is a new gen B2B platform for diverse portofolio needs.

Flag India
Digital Content Digital Content

RLD : No

TE Code :

URSODIOL

Brand Name : URSODIOL

Dosage Form : CAPSULE;ORAL

Dosage Strength : 150MG

Approval Date : 2026-01-16

Application Number : 210344

RX/OTC/DISCN : RX

RLD : No

TE Code :

Strides Pharma Science

03

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothSynergice, a Strides Pharma initiative, is a new gen B2B platform for diverse portofolio needs.

Flag India
Digital Content Digital Content

RLD : No

TE Code : AB

URSODIOL

Brand Name : URSODIOL

Dosage Form : TABLET;ORAL

Dosage Strength : 250MG

Approval Date : 2020-08-20

Application Number : 213504

RX/OTC/DISCN : RX

RLD : No

TE Code : AB

Strides Pharma Science

04

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothSynergice, a Strides Pharma initiative, is a new gen B2B platform for diverse portofolio needs.

Flag India
Digital Content Digital Content

RLD : No

TE Code : AB

URSODIOL

Brand Name : URSODIOL

Dosage Form : TABLET;ORAL

Dosage Strength : 500MG

Approval Date : 2020-08-20

Application Number : 213504

RX/OTC/DISCN : RX

RLD : No

TE Code : AB

Strides Pharma Science

05

ABBVIE

U.S.A

URSODIOL

Brand Name : URSO 250

Dosage Form : TABLET;ORAL

Dosage Strength : 250MG

Approval Date : 1997-12-10

Application Number : 20675

RX/OTC/DISCN : DISCN

RLD : Yes

TE Code :

Abbvie Company Banner

06

ABBVIE

U.S.A

URSODIOL

Brand Name : URSO FORTE

Dosage Form : TABLET;ORAL

Dosage Strength : 500MG

Approval Date : 2004-07-21

Application Number : 20675

RX/OTC/DISCN : DISCN

RLD : Yes

TE Code :

Abbvie Company Banner

07

LGM PHARMA

U.S.A
  • fda
  • EDQM
  • WHO-GMP

Virtual BoothLGM Pharma accelerates & optimizes the new product pathway from early development through commercialization.

Flag U.S.A
Digital Content Digital Content

RLD : No

TE Code :

URSODIOL

Brand Name : URSODIOL

Dosage Form : CAPSULE;ORAL

Dosage Strength : 200MG

Approval Date : 2020-05-08

Application Number : 205789

RX/OTC/DISCN : RX

RLD : No

TE Code :

LGM Pharma CB

08

LGM PHARMA

U.S.A
  • fda
  • EDQM
  • WHO-GMP

Virtual BoothLGM Pharma accelerates & optimizes the new product pathway from early development through commercialization.

Flag U.S.A
Digital Content Digital Content

RLD : No

TE Code :

URSODIOL

Brand Name : URSODIOL

Dosage Form : CAPSULE;ORAL

Dosage Strength : 400MG

Approval Date : 2020-05-08

Application Number : 205789

RX/OTC/DISCN : RX

RLD : No

TE Code :

LGM Pharma CB

09

QUAGEN

U.S.A
CPhI Japan
Not Confirmed
arrow

QUAGEN

U.S.A
arrow
CPhI Japan
Not Confirmed

URSODIOL

Brand Name : URSODIOL

Dosage Form : CAPSULE;ORAL

Dosage Strength : 300MG

Approval Date : 2010-02-17

Application Number : 90530

RX/OTC/DISCN : DISCN

RLD : No

TE Code :

blank

10

CPhI Japan
Not Confirmed
arrow
arrow
CPhI Japan
Not Confirmed

URSODIOL

Brand Name : URSODIOL

Dosage Form : TABLET;ORAL

Dosage Strength : 500MG

Approval Date : 2009-05-13

Application Number : 79184

RX/OTC/DISCN : DISCN

RLD : No

TE Code :

blank
click full view
Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

Europe

read-more
read-more

01

Ursodeoxycholic Acid

Brand Name : Ursodeoxycholsyre \"Orion\"

Dosage Form : Hard Capsules

Dosage Strength : 250mg

Packaging :

Approval Date : 11-09-2017

Application Number : 28105897916

Regulatory Info : Prescription

Registration Country : Denmark

Fermion Orion Company Banner

02

Ursodeoxycholic Acid

Brand Name : Ursodeoxycholic Acid Orion

Dosage Form : Capsule

Dosage Strength : 250mg

Packaging :

Approval Date : 11-09-2017

Application Number : 2.02E+13

Regulatory Info : Approved

Registration Country : Sweden

Fermion Orion Company Banner

03

CPhI Japan
Not Confirmed
arrow
arrow
CPhI Japan
Not Confirmed

Ursodeoxycholic acid

Brand Name : URSODEOXYCHOLIC ACID DOC GENERIC

Dosage Form : Hard Capsules

Dosage Strength : 300 mg

Packaging : 20 UNITS 300 MG - ORAL USE

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Italy

blank

04

CPhI Japan
Not Confirmed
arrow
arrow
CPhI Japan
Not Confirmed

Ursodeoxycholic Acid

Brand Name : Ursofalk

Dosage Form : Capsule

Dosage Strength : 250mg

Packaging :

Approval Date : 06/08/1980

Application Number : 42782

Regulatory Info : Allowed

Registration Country : Switzerland

blank

05

CPhI Japan
Not Confirmed
arrow
arrow
CPhI Japan
Not Confirmed

Ursodeoxycholic Acid

Brand Name : Ursochol

Dosage Form : Hard Capsules

Dosage Strength : 500mg

Packaging :

Approval Date : 02-09-2014

Application Number : 28105309413

Regulatory Info : Prescription

Registration Country : Denmark

blank

06

Pro.Med.Cs Praha As

Czech Republic
CPhI Japan
Not Confirmed
arrow

Pro.Med.Cs Praha As

Czech Republic
arrow
CPhI Japan
Not Confirmed

Ursodeoxycholic Acid

Brand Name : Ursosan

Dosage Form : Film Coated Tablet

Dosage Strength : 500mg

Packaging :

Approval Date : 03-04-2014

Application Number : 2.01E+13

Regulatory Info : Approved

Registration Country : Sweden

blank

07

MYLAN SPA

U.S.A
CPhI Japan
Not Confirmed
arrow

MYLAN SPA

U.S.A
arrow
CPhI Japan
Not Confirmed

Ursodeoxycholic acid

Brand Name : URSODEOXYCHOLIC ACID MYLAN GENERICS

Dosage Form : Tablets

Dosage Strength : 150 mg

Packaging : 20 UNITS 150 MG - ORAL USE

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Italy

blank

08

ANGENERICO SpA

Country
CPhI Japan
Not Confirmed
arrow

ANGENERICO SpA

Country
arrow
CPhI Japan
Not Confirmed

Ursodeoxycholic Acid

Brand Name : Ursodessicolico Acid

Dosage Form : Ursodeoxycholic Acid 300Mg 20 Joined' Oral Use

Dosage Strength : 20 cps 300 mg

Packaging :

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Italy

blank

09

MAGIS FARMACEUTICI Srl

Country
CPhI Japan
Not Confirmed
arrow

MAGIS FARMACEUTICI Srl

Country
arrow
CPhI Japan
Not Confirmed

Ursodeoxycholic Acid

Brand Name : Ursolisin

Dosage Form : Ursodeoxycholic Acid 150Mg 20 Joined' Oral Use

Dosage Strength : 20 cps 150 mg

Packaging :

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Italy

blank

10

ERREKAPPA EUROTERAPICI SpA

Country
CPhI Japan
Not Confirmed
arrow

ERREKAPPA EUROTERAPICI SpA

Country
arrow
CPhI Japan
Not Confirmed

Ursodeoxycholic Acid

Brand Name : Urdes

Dosage Form : Ursodeoxycholic Acid 225Mg 20 Joined' Oral Use

Dosage Strength : 20 cpr gastrores 225 mg

Packaging :

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Italy

blank
click full view
Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

Canada

read-more
read-more

01

CPhI Japan
Not Confirmed
arrow
arrow
CPhI Japan
Not Confirmed

URSODIOL

Brand Name : GLN-URSODIOL

Dosage Form : TABLET

Dosage Strength : 250MG

Packaging :

Approval Date :

Application Number : 2426900

Regulatory Info : PRESCRIPTION

Registration Country : Canada

blank

02

CPhI Japan
Not Confirmed
arrow
arrow
CPhI Japan
Not Confirmed

URSODIOL

Brand Name : GLN-URSODIOL

Dosage Form : TABLET

Dosage Strength : 500MG

Packaging :

Approval Date :

Application Number : 2426919

Regulatory Info : PRESCRIPTION

Registration Country : Canada

blank

03

CPhI Japan
Not Confirmed
arrow
arrow
CPhI Japan
Not Confirmed

URSODIOL

Brand Name : JAMP-URSODIOL

Dosage Form : TABLET

Dosage Strength : 250MG

Packaging : 100/500

Approval Date :

Application Number : 2472392

Regulatory Info : PRESCRIPTION

Registration Country : Canada

blank

04

CPhI Japan
Not Confirmed
arrow
arrow
CPhI Japan
Not Confirmed

URSODIOL

Brand Name : JAMP-URSODIOL

Dosage Form : TABLET

Dosage Strength : 500MG

Packaging : 100

Approval Date :

Application Number : 2472406

Regulatory Info : PRESCRIPTION

Registration Country : Canada

blank

05

CPhI Japan
Not Confirmed
arrow
arrow
CPhI Japan
Not Confirmed

URSODIOL

Brand Name : NRA-URSODIOL

Dosage Form : TABLET

Dosage Strength : 500MG

Packaging :

Approval Date :

Application Number : 2544024

Regulatory Info : PRESCRIPTION

Registration Country : Canada

blank

06

CPhI Japan
Not Confirmed
arrow
arrow
CPhI Japan
Not Confirmed

URSODIOL

Brand Name : NRA-URSODIOL

Dosage Form : TABLET

Dosage Strength : 250MG

Packaging :

Approval Date :

Application Number : 2544032

Regulatory Info : PRESCRIPTION

Registration Country : Canada

blank

07

CPhI Japan
Not Confirmed
arrow
arrow
CPhI Japan
Not Confirmed

Ursodeoxycholic Acid

Brand Name : PMS-URSODIOL C

Dosage Form : TABLET

Dosage Strength : 250MG

Packaging : 100/500

Approval Date :

Application Number :

Regulatory Info : Prescription

Registration Country : Canada

blank

08

CPhI Japan
Not Confirmed
arrow
arrow
CPhI Japan
Not Confirmed

Ursodeoxycholic Acid

Brand Name : PMS-URSODIOL C

Dosage Form : TABLET

Dosage Strength : 500MG

Packaging : 100

Approval Date :

Application Number :

Regulatory Info : Prescription

Registration Country : Canada

blank

09

CPhI Japan
Not Confirmed
arrow
arrow
CPhI Japan
Not Confirmed

URSODIOL

Brand Name : PMS-URSODIOL C

Dosage Form : TABLET

Dosage Strength : 250MG

Packaging : 100/500

Approval Date :

Application Number : 2273497

Regulatory Info : PRESCRIPTION

Registration Country : Canada

blank

10

CPhI Japan
Not Confirmed
arrow
arrow
CPhI Japan
Not Confirmed

URSODIOL

Brand Name : PMS-URSODIOL C

Dosage Form : TABLET

Dosage Strength : 500MG

Packaging : 100

Approval Date :

Application Number : 2273500

Regulatory Info : PRESCRIPTION

Registration Country : Canada

blank
Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

Australia

read-more
read-more

01

CPhI Japan
Not Confirmed
arrow
arrow
CPhI Japan
Not Confirmed

Ursodeoxycholic acid

Brand Name : APO-Ursodeoxycholic acid

Dosage Form : capsule

Dosage Strength : 250 mg

Packaging : 100

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Australia

blank

02

CPhI Japan
Not Confirmed
arrow
arrow
CPhI Japan
Not Confirmed

Ursodeoxycholic acid

Brand Name : Ursosan

Dosage Form : capsule

Dosage Strength : 250 mg

Packaging : 100

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Australia

blank

03

CPhI Japan
Not Confirmed
arrow
arrow
CPhI Japan
Not Confirmed

Ursodeoxycholic acid

Brand Name : Ursofalk

Dosage Form :

Dosage Strength :

Packaging : 100

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Australia

blank

04

CPhI Japan
Not Confirmed
arrow
arrow
CPhI Japan
Not Confirmed

Ursodeoxycholic acid

Brand Name : Ursofalk

Dosage Form : capsule

Dosage Strength : 250 mg

Packaging : 100

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Australia

blank

05

CPhI Japan
Not Confirmed
arrow
arrow
CPhI Japan
Not Confirmed

Ursodeoxycholic acid

Brand Name : Ursodox GH

Dosage Form :

Dosage Strength :

Packaging : 100

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Australia

blank

06

CPhI Japan
Not Confirmed
arrow
arrow
CPhI Japan
Not Confirmed

Ursodeoxycholic acid

Brand Name : Ursodox GH

Dosage Form : capsule

Dosage Strength : 250 mg

Packaging : 100

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Australia

blank
Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

South Africa

read-more
read-more

01

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothSanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.

Flag France
Digital Content Digital Content

Regulatory Info : Originator

Registration Country : South Africa

Ursodeoxycholic Acid

Brand Name : Ursotan

Dosage Form : TAB

Dosage Strength : 100mg

Packaging : 180X1mg

Approval Date :

Application Number :

Regulatory Info : Originator

Registration Country : South Africa

Sanofi Company Banner

02

Cipla Medpro (Pty) Ltd

South Africa
CPhI Japan
Not Confirmed
arrow

Cipla Medpro (Pty) Ltd

South Africa
arrow
CPhI Japan
Not Confirmed

Ursodeoxycholic acid

Brand Name : Ursofalk

Dosage Form : CAP

Dosage Strength : 250mg

Packaging : 100X1mg

Approval Date :

Application Number :

Regulatory Info : Originator

Registration Country : South Africa

blank
Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

Listed Dossiers

read-more
read-more

01

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothSynergice, a Strides Pharma initiative, is a new gen B2B platform for diverse portofolio needs.

Flag India
Digital Content Digital Content

Regulatory Info :

Registration Country : India

Ursodeoxycholic acid

Brand Name : Ursodeoxycholic acid

Dosage Form : Capsule

Dosage Strength : 250MG

Packaging :

Approval Date :

Application Number :

Regulatory Info :

Registration Country : India

Strides Pharma Science

01

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothSynergice, a Strides Pharma initiative, is a new gen B2B platform for diverse portofolio needs.

Flag India
Digital Content Digital Content

Packaging :

Regulatory Info :

Ursodeoxycholic acid

Dosage : Capsule

Dosage Strength : 250MG

Brand Name : Ursodeoxycholic acid

Approval Date :

Application Number :

Registration Country : India

Strides Pharma Science

02

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothSynergice, a Strides Pharma initiative, is a new gen B2B platform for diverse portofolio needs.

Flag India
Digital Content Digital Content

Regulatory Info :

Registration Country : India

Ursodeoxycholic acid

Brand Name : Ursodeoxycholic acid

Dosage Form : Capsule

Dosage Strength : 300MG

Packaging :

Approval Date :

Application Number :

Regulatory Info :

Registration Country : India

Strides Pharma Science

02

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothSynergice, a Strides Pharma initiative, is a new gen B2B platform for diverse portofolio needs.

Flag India
Digital Content Digital Content

Packaging :

Regulatory Info :

Ursodeoxycholic acid

Dosage : Capsule

Dosage Strength : 300MG

Brand Name : Ursodeoxycholic acid

Approval Date :

Application Number :

Registration Country : India

Strides Pharma Science

03

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothSynergice, a Strides Pharma initiative, is a new gen B2B platform for diverse portofolio needs.

Flag India
Digital Content Digital Content

Regulatory Info :

Registration Country : India

Ursodiol

Brand Name : Ursodiol

Dosage Form : Tablet

Dosage Strength : 250MG

Packaging :

Approval Date :

Application Number :

Regulatory Info :

Registration Country : India

Strides Pharma Science

03

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothSynergice, a Strides Pharma initiative, is a new gen B2B platform for diverse portofolio needs.

Flag India
Digital Content Digital Content

Packaging :

Regulatory Info :

Ursodiol

Dosage : Tablet

Dosage Strength : 250MG

Brand Name : Ursodiol

Approval Date :

Application Number :

Registration Country : India

Strides Pharma Science

04

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothSynergice, a Strides Pharma initiative, is a new gen B2B platform for diverse portofolio needs.

Flag India
Digital Content Digital Content

Regulatory Info :

Registration Country : India

Ursodiol

Brand Name : Ursodiol

Dosage Form : Tablet

Dosage Strength : 500MG

Packaging :

Approval Date :

Application Number :

Regulatory Info :

Registration Country : India

Strides Pharma Science

04

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothSynergice, a Strides Pharma initiative, is a new gen B2B platform for diverse portofolio needs.

Flag India
Digital Content Digital Content

Packaging :

Regulatory Info :

Ursodiol

Dosage : Tablet

Dosage Strength : 500MG

Brand Name : Ursodiol

Approval Date :

Application Number :

Registration Country : India

Strides Pharma Science

05

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothOctavius Pharma has been empowering lives since 1980 by providing quality products like DC granules, APIs and FDFs.

Flag India
Digital Content Digital Content

Regulatory Info :

Registration Country : India

Ursodeoxycholic Acid

Brand Name : Ursodeoxycholic Acid

Dosage Form : Capsule

Dosage Strength : 250MG

Packaging :

Approval Date :

Application Number :

Regulatory Info :

Registration Country : India

Octavius Pharma

05

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothOctavius Pharma has been empowering lives since 1980 by providing quality products like DC granules, APIs and FDFs.

Flag India
Digital Content Digital Content

Packaging :

Regulatory Info :

Ursodeoxycholic Acid

Dosage : Capsule

Dosage Strength : 250MG

Brand Name : Ursodeoxycholic Acid

Approval Date :

Application Number :

Registration Country : India

Octavius Pharma

06

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothOctavius Pharma has been empowering lives since 1980 by providing quality products like DC granules, APIs and FDFs.

Flag India
Digital Content Digital Content

Regulatory Info :

Registration Country : India

Ursodeoxycholic Acid

Brand Name : Ursodeoxycholic Acid

Dosage Form : Capsule

Dosage Strength : 300MG

Packaging :

Approval Date :

Application Number :

Regulatory Info :

Registration Country : India

Octavius Pharma

06

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothOctavius Pharma has been empowering lives since 1980 by providing quality products like DC granules, APIs and FDFs.

Flag India
Digital Content Digital Content

Packaging :

Regulatory Info :

Ursodeoxycholic Acid

Dosage : Capsule

Dosage Strength : 300MG

Brand Name : Ursodeoxycholic Acid

Approval Date :

Application Number :

Registration Country : India

Octavius Pharma

07

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothOctavius Pharma has been empowering lives since 1980 by providing quality products like DC granules, APIs and FDFs.

Flag India
Digital Content Digital Content

Regulatory Info :

Registration Country : India

Ursodeoxycholic Acid

Brand Name : Ursodeoxycholic Acid

Dosage Form : DC Granules

Dosage Strength : 250MG

Packaging :

Approval Date :

Application Number :

Regulatory Info :

Registration Country : India

Octavius Pharma

07

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothOctavius Pharma has been empowering lives since 1980 by providing quality products like DC granules, APIs and FDFs.

Flag India
Digital Content Digital Content

Packaging :

Regulatory Info :

Ursodeoxycholic Acid

Dosage : DC Granules

Dosage Strength : 250MG

Brand Name : Ursodeoxycholic Acid

Approval Date :

Application Number :

Registration Country : India

Octavius Pharma

08

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothOctavius Pharma has been empowering lives since 1980 by providing quality products like DC granules, APIs and FDFs.

Flag India
Digital Content Digital Content

Regulatory Info :

Registration Country : India

Ursodeoxycholic Acid

Brand Name : Ursodeoxycholic Acid

Dosage Form : DC Granules

Dosage Strength : 300MG

Packaging :

Approval Date :

Application Number :

Regulatory Info :

Registration Country : India

Octavius Pharma

08

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothOctavius Pharma has been empowering lives since 1980 by providing quality products like DC granules, APIs and FDFs.

Flag India
Digital Content Digital Content

Packaging :

Regulatory Info :

Ursodeoxycholic Acid

Dosage : DC Granules

Dosage Strength : 300MG

Brand Name : Ursodeoxycholic Acid

Approval Date :

Application Number :

Registration Country : India

Octavius Pharma

09

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothOctavius Pharma has been empowering lives since 1980 by providing quality products like DC granules, APIs and FDFs.

Flag India
Digital Content Digital Content

Regulatory Info :

Registration Country : India

Ursodeoxycholic Acid

Brand Name : Ursodeoxycholic Acid

Dosage Form : Tablet

Dosage Strength : 200MG

Packaging :

Approval Date :

Application Number :

Regulatory Info :

Registration Country : India

Octavius Pharma

09

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothOctavius Pharma has been empowering lives since 1980 by providing quality products like DC granules, APIs and FDFs.

Flag India
Digital Content Digital Content

Packaging :

Regulatory Info :

Ursodeoxycholic Acid

Dosage : Tablet

Dosage Strength : 200MG

Brand Name : Ursodeoxycholic Acid

Approval Date :

Application Number :

Registration Country : India

Octavius Pharma

10

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothOctavius Pharma has been empowering lives since 1980 by providing quality products like DC granules, APIs and FDFs.

Flag India
Digital Content Digital Content

Regulatory Info :

Registration Country : India

Ursodeoxycholic Acid

Brand Name : Ursodeoxycholic Acid

Dosage Form : Tablet

Dosage Strength : 250MG

Packaging :

Approval Date :

Application Number :

Regulatory Info :

Registration Country : India

Octavius Pharma

10

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothOctavius Pharma has been empowering lives since 1980 by providing quality products like DC granules, APIs and FDFs.

Flag India
Digital Content Digital Content

Packaging :

Regulatory Info :

Ursodeoxycholic Acid

Dosage : Tablet

Dosage Strength : 250MG

Brand Name : Ursodeoxycholic Acid

Approval Date :

Application Number :

Registration Country : India

Octavius Pharma
click full view
Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

DRUG PRODUCT COMPOSITIONS

Do you need Business Intel? Ask us

DOSAGE - CAPSULE;ORAL - 300MG

USFDA APPLICATION NUMBER - 19594

read-more

DOSAGE - TABLET;ORAL - 250MG

USFDA APPLICATION NUMBER - 20675

read-more

DOSAGE - TABLET;ORAL - 500MG

USFDA APPLICATION NUMBER - 20675

read-more

Related Excipient Companies

Upload your portfolio for free, ask us

Excipients by Applications

Click here to find the perfect excipient manufacturers by their capabilities

Fillers, Diluents & Binders

read-more
read-more

Coating Systems & Additives

read-more
read-more

Granulation

read-more
read-more

Controlled & Modified Release

read-more
read-more

Direct Compression

read-more
read-more

Thickeners and Stabilizers

read-more
read-more

Film Formers & Plasticizers

read-more
read-more

Solubilizers

read-more
read-more

Topical

read-more
read-more

Taste Masking

read-more
read-more

Disintegrants & Superdisintegrants

read-more
read-more

Lubricants & Glidants

read-more
read-more

Co-Processed Excipients

read-more
read-more

Chewable & Orodispersible Aids

read-more
read-more

Parenteral

read-more
read-more

Empty Capsules

read-more
read-more

Emulsifying Agents

read-more
read-more

Rheology Modifiers

read-more
read-more

API Stability Enhancers

read-more
read-more

Vegetarian Capsules

read-more
read-more

Surfactant & Foaming Agents

read-more
read-more

Coloring Agents

read-more
read-more

Soft Gelatin

read-more
read-more

Digital Content read-more

Create Content with PharmaCompass, ask us

DATA COMPILATION #PharmaFlow

read-more
read-more

NEWS #PharmaBuzz

read-more
read-more

Global Sales Information

Do you need Business Intel? Ask us

US Medicaid Prescriptions

read-more
read-more

01

arrow
CPhI Japan
Not Confirmed
arrow
CPhI Japan
Not Confirmed

Company : Intra-Sana Labo

Ursodiol

Drug Cost (USD) : 560,473

Year : 2023

Prescribers : 110

Prescriptions : 257

blank

02

arrow
CPhI Japan
Not Confirmed
arrow
CPhI Japan
Not Confirmed

Company : Aptalis/Allerga

Ursodiol

Drug Cost (USD) : 157,115

Year : 2023

Prescribers : 26

Prescriptions : 151

blank

03

arrow
CPhI Japan
Not Confirmed
arrow
CPhI Japan
Not Confirmed

Company : Aptalis/Allerga

Ursodiol

Drug Cost (USD) : 391,797

Year : 2023

Prescribers : 72

Prescriptions : 304

blank

04

arrow
CPhI Japan
Not Confirmed
arrow
CPhI Japan
Not Confirmed

Company : AHP

Ursodiol

Drug Cost (USD) : 1,194

Year : 2023

Prescribers :

Prescriptions : 15

blank

05

arrow
CPhI Japan
Not Confirmed
arrow
CPhI Japan
Not Confirmed

Company : Actavis/Teva

Ursodiol

Drug Cost (USD) : 9,318,870

Year : 2023

Prescribers : 15107

Prescriptions : 46894

blank

06

arrow
CPhI Japan
Not Confirmed
arrow
CPhI Japan
Not Confirmed

Company : Amneal Pharmace

Ursodiol

Drug Cost (USD) : 17,486,445

Year : 2023

Prescribers : 28335

Prescriptions : 94283

blank

07

arrow
CPhI Japan
Not Confirmed
arrow
CPhI Japan
Not Confirmed

Company : Aurobindo Pharm

Ursodiol

Drug Cost (USD) : 4,035,013

Year : 2023

Prescribers : 10015

Prescriptions : 23005

blank

08

arrow
CPhI Japan
Not Confirmed
arrow
CPhI Japan
Not Confirmed

Company : Bluepoint Labor

Ursodiol

Drug Cost (USD) : 1,905,626

Year : 2023

Prescribers : 2576

Prescriptions : 9376

blank

09

arrow
CPhI Japan
Not Confirmed
arrow
CPhI Japan
Not Confirmed

Company : Epic Pharma LLC

Ursodiol

Drug Cost (USD) : 10,575,199

Year : 2023

Prescribers : 16548

Prescriptions : 48374

blank

10

arrow
CPhI Japan
Not Confirmed
arrow
CPhI Japan
Not Confirmed

Company : Eywa Pharma Inc

Ursodiol

Drug Cost (USD) : 70,345

Year : 2023

Prescribers : 328

Prescriptions : 775

blank
click full view
Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

Market Place

Do you need sourcing support? Ask us

REF. STANDARDS & IMPURITIES

Upload your portfolio for free, ask us

ANALYTICAL

Upload your methods for free, ask us

ABOUT THIS PAGE

Looking for 128-13-2 / Ursodeoxycholic Acid API manufacturers, exporters & distributors?

Ursodeoxycholic Acid manufacturers, exporters & distributors 1

69

PharmaCompass offers a list of Ursodeoxycholic Acid API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, and more, enabling you to easily find the right Ursodeoxycholic Acid manufacturer or Ursodeoxycholic Acid supplier for your needs.

Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Ursodeoxycholic Acid manufacturer or Ursodeoxycholic Acid supplier.

API | Excipient name

Ursodeoxycholic Acid

Synonyms

Ursodiol, 128-13-2, Actigall, Ursodeoxycholate, Udca, Ursofalk

Cas Number

128-13-2

Unique Ingredient Identifier (UNII)

724L30Y2QR

About Ursodeoxycholic Acid

An epimer of chenodeoxycholic acid. It is a mammalian bile acid found first in the bear and is apparently either a precursor or a product of chenodeoxycholate. Its administration changes the composition of bile and may dissolve gallstones. It is used as a cholagogue and choleretic.

Prestwick3_000958 Manufacturers

A Prestwick3_000958 manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Prestwick3_000958, including repackagers and relabelers. The FDA regulates Prestwick3_000958 manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Prestwick3_000958 API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.

click here to find a list of Prestwick3_000958 manufacturers with USDMF, JDMF, KDMF, CEP, GMP, and COA related information on PhamaCompass.

Prestwick3_000958 Suppliers

A Prestwick3_000958 supplier is an individual or a company that provides Prestwick3_000958 active pharmaceutical ingredient (API) or Prestwick3_000958 finished formulations upon request. The Prestwick3_000958 suppliers may include Prestwick3_000958 API manufacturers, exporters, distributors and traders.

click here to find a list of Prestwick3_000958 suppliers with USDMF, JDMF, KDMF, CEP, GMP, and COA related information on PharmaCompass.

Prestwick3_000958 USDMF

A Prestwick3_000958 DMF (Drug Master File) is a document detailing the whole manufacturing process of Prestwick3_000958 active pharmaceutical ingredient (API) in detail. Different forms of Prestwick3_000958 DMFs exist exist since differing nations have different regulations, such as Prestwick3_000958 USDMF, ASMF (EDMF), JDMF, CDMF, etc.

A Prestwick3_000958 DMF submitted to regulatory agencies in the US is known as a USDMF. Prestwick3_000958 USDMF includes data on Prestwick3_000958's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The Prestwick3_000958 USDMF is kept confidential to protect the manufacturer’s intellectual property.

click here to find a list of Prestwick3_000958 suppliers with USDMF on PharmaCompass.

Prestwick3_000958 JDMF

The Pharmaceuticals and Medical Devices Agency (PMDA) established the Japan Drug Master File (JDMF), also known as the Master File (MF), to permit Japanese and foreign manufacturers of drug substances, intermediates, excipients, raw materials, and packaging materials (‘Products’) to voluntarily register confidential information about the production and management of their products in Japan.

The Prestwick3_000958 Drug Master File in Japan (Prestwick3_000958 JDMF) empowers Prestwick3_000958 API manufacturers to present comprehensive information (e.g., production methods, data, etc.) to the review authority, i.e., PMDA (Pharmaceuticals & Medical Devices Agency).

PMDA reviews the Prestwick3_000958 JDMF during the approval evaluation for pharmaceutical products. At the time of Prestwick3_000958 JDMF registration, PMDA checks if the format is accurate, if the necessary items have been included (application), and if data has been attached.

click here to find a list of Prestwick3_000958 suppliers with JDMF on PharmaCompass.

Prestwick3_000958 KDMF

In Korea, the Ministry of Food and Drug Safety (MFDS) is in charge of regulating pharmaceutical products and services.

Pharmaceutical companies submit a Prestwick3_000958 Drug Master File in Korea (Prestwick3_000958 KDMF) to the MFDS, which includes comprehensive information about the production, processing, facilities, materials, packaging, and testing of Prestwick3_000958. The MFDS reviews the Prestwick3_000958 KDMF as part of the drug registration process and uses the information provided in the Prestwick3_000958 KDMF to evaluate the safety and efficacy of the drug.

After submitting a Prestwick3_000958 KDMF to the MFDS, the registered manufacturer can provide importers or distributors with the registration number without revealing confidential information to Korean business partners. Applicants seeking to register their Prestwick3_000958 API can apply through the Korea Drug Master File (KDMF).

click here to find a list of Prestwick3_000958 suppliers with KDMF on PharmaCompass.

Prestwick3_000958 CEP

A Prestwick3_000958 CEP of the European Pharmacopoeia monograph is often referred to as a Prestwick3_000958 Certificate of Suitability (COS). The purpose of a Prestwick3_000958 CEP is to show that the European Pharmacopoeia monograph adequately controls the purity of Prestwick3_000958 EP produced by a given manufacturer. Suppliers of raw materials can prove the suitability of Prestwick3_000958 to their clients by showing that a Prestwick3_000958 CEP has been issued for it. The manufacturer submits a Prestwick3_000958 CEP (COS) as part of the market authorization procedure, and it takes on the role of a Prestwick3_000958 CEP holder for the record. Additionally, the data presented in the Prestwick3_000958 CEP (COS) is managed confidentially and offers a centralized system acknowledged by numerous nations, exactly like the Prestwick3_000958 DMF.

A Prestwick3_000958 CEP (COS) is recognised by all 36 nations that make up the European Pharmacopoeia Convention. Prestwick3_000958 CEPs may be accepted in nations that are not members of the Ph. Eur. at the discretion of the authorities there.

click here to find a list of Prestwick3_000958 suppliers with CEP (COS) on PharmaCompass.

Prestwick3_000958 WC

A Prestwick3_000958 written confirmation (Prestwick3_000958 WC) is an official document issued by a regulatory agency to a Prestwick3_000958 manufacturer, verifying that the manufacturing facility of a Prestwick3_000958 active pharmaceutical ingredient (API) adheres to the Good Manufacturing Practices (GMP) regulations of the importing country. When exporting Prestwick3_000958 APIs or Prestwick3_000958 finished pharmaceutical products to another nation, regulatory agencies frequently require a Prestwick3_000958 WC (written confirmation) as part of the regulatory process.

click here to find a list of Prestwick3_000958 suppliers with Written Confirmation (WC) on PharmaCompass.

Prestwick3_000958 NDC

National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Prestwick3_000958 as an active pharmaceutical ingredient (API).

Finished drug products

The FDA updates the NDC directory daily. The NDC numbers for Prestwick3_000958 API and other APIs are published in this directory by the FDA.

Unfinished drugs

The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.

Pharmaceutical companies that manufacture Prestwick3_000958 as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.

Compounded drug products

The NDC directory also contains data on finished compounded human drug products that contain Prestwick3_000958 and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Prestwick3_000958 NDC to their finished compounded human drug products, they may choose to do so.

click here to find a list of Prestwick3_000958 suppliers with NDC on PharmaCompass.

Prestwick3_000958 GMP

Prestwick3_000958 Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.

GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).

PharmaCompass offers a list of Prestwick3_000958 GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, and more, enabling you to easily find the right Prestwick3_000958 GMP manufacturer or Prestwick3_000958 GMP API supplier for your needs.

Prestwick3_000958 CoA

A Prestwick3_000958 CoA (Certificate of Analysis) is a formal document that attests to Prestwick3_000958's compliance with Prestwick3_000958 specifications and serves as a tool for batch-level quality control.

Prestwick3_000958 CoA mostly includes findings from lab analyses of a specific batch. For each Prestwick3_000958 CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.

Prestwick3_000958 may be tested according to a variety of international standards, such as European Pharmacopoeia (Prestwick3_000958 EP), Prestwick3_000958 JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Prestwick3_000958 USP).

Inform the supplier about your product requirements, specifying if you need a product with particular monograph like EP (Ph. Eur.), USP, JP, BP, or any other quality. In addition, clarify whether you need hydrochloride (HCl), anhydricum, base, micronisatum or a specific level of purity. To find reputable suppliers, utilize the filters and select those certified by GMP, FDA, or any other certification as per your requirement.
For your convenience, we have listed synonyms and CAS numbers to help you find the best supplier. The use of synonyms and CAS numbers can be helpful in identifying potential suppliers, but it is crucial to note that they might not always indicate the exact same product. It is important to confirm the product details with the supplier before making a purchase to ensure that it meets your requirements.
Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty